Tumor Hybrid Cells: Nature and Biological Significance

Metastasis is the leading cause of cancer death and can be realized through the phenomenon of tumor cell fusion. The fusion of tumor cells with other tumor or normal cells leads to the appearance of tumor hybrid cells (THCs) exhibiting novel properties such as increased proliferation and migration, drug resistance, decreased apoptosis rate, and avoiding immune surveillance. Experimental studies showed the association of THCs with a high frequency of cancer metastasis; however, the underlying mechanisms remain unclear. Many other questions also remain to be answered: the role of genetic alterations in tumor cell fusion, the molecular landscape of cells after fusion, the lifetime and fate of different THCs, and the specific markers of THCs, and their correlation with various cancers and clinicopathological parameters. In this review, we discuss the factors and potential mechanisms involved in the occurrence of THCs, the types of THCs, and their role in cancer drug resistance and metastasis, as well as potential therapeutic approaches for the prevention, and targeting of tumor cell fusion. In conclusion, we emphasize the current knowledge gaps in the biology of THCs that should be addressed to develop highly effective therapeutics and strategies for metastasis suppression.

[1]  T. Dittmar,et al.  Hybrid Formation and Fusion of Cancer Cells In Vitro and In Vivo , 2021, Cancers.

[2]  F. Chibon,et al.  Cell fusion enhances energy metabolism of mesenchymal tumor hybrid cells to sustain their proliferation and invasion , 2021, BMC cancer.

[3]  H. Levine,et al.  Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype , 2021, bioRxiv.

[4]  J. Weiler,et al.  Cell–Cell Fusion and the Roads to Novel Properties of Tumor Hybrid Cells , 2021, Cells.

[5]  Michael R Hamblin,et al.  Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead , 2021, Cells.

[6]  J. Pawelek,et al.  A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis. , 2021, Cancer genetics.

[7]  R. Hass,et al.  Spontaneous Fusion of MSC with Breast Cancer Cells Can Generate Tumor Dormancy , 2021, International journal of molecular sciences.

[8]  M. Jolly,et al.  A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells , 2021, bioRxiv.

[9]  Matthew S. Dietz,et al.  Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors , 2021, Scientific Reports.

[10]  F. Chibon,et al.  Acquisition of cancer stem cell capacities after spontaneous cell fusion , 2021, BMC cancer.

[11]  Jarred M. Whitlock,et al.  Flagging fusion: Phosphatidylserine signaling in cell–cell fusion , 2021, The Journal of biological chemistry.

[12]  A. Tan,et al.  Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations , 2021, Nature Ecology & Evolution.

[13]  R. Hoffman,et al.  Color-Coded Imaging of Cancer and Stromal-Cell Interaction in the Pancreatic-Cancer Tumor Microenvironment (TME). , 2021, Methods in molecular biology.

[14]  S. Sen,et al.  EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer , 2021, Frontiers in Cell and Developmental Biology.

[15]  S. Benichou,et al.  Virus-Mediated Cell-Cell Fusion , 2020, International journal of molecular sciences.

[16]  R. Hass,et al.  Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC , 2020, International journal of molecular sciences.

[17]  Jeffrey E. Lee,et al.  Virus and eukaryote fusogen superfamilies , 2020, Current Biology.

[18]  H. Ko,et al.  Dual role of phosphatidylserine and its receptors in osteoclastogenesis , 2020, Cell Death & Disease.

[19]  P. Leung,et al.  NPFF increases fusogenic proteins syncytin 1 and syncytin 2 via GCM1 in first trimester primary human cytotrophoblast cells , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  T. Dittmar,et al.  Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties , 2020, BMC Cancer.

[21]  F. Chibon,et al.  Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread , 2020, Oncogene.

[22]  Leon N. Schulte,et al.  Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells , 2020, Oncoimmunology.

[23]  岡田 伸太郎,et al.  Matrix Metalloproteinase-9 , 1998, Definitions.

[24]  M. Truffi,et al.  Fibroblasts in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.

[25]  Ying-Hui Huang,et al.  Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway. , 2019, Archives of biochemistry and biophysics.

[26]  M. Jolly,et al.  Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis. , 2019, Cold Spring Harbor perspectives in medicine.

[27]  D. Fletcher,et al.  A viral fusogen hijacks the actin cytoskeleton to drive cell-cell fusion , 2019, bioRxiv.

[28]  M. Shimojima,et al.  Cell–cell fusion induced by reovirus FAST proteins enhances replication and pathogenicity of non-enveloped dsRNA viruses , 2019, PLoS pathogens.

[29]  D. B. Hibbert,et al.  Lipopolysaccharide (Lps) , 2019, IUPAC Standards Online.

[30]  H. Yao,et al.  Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy , 2019, Clinical Cancer Research.

[31]  J. Faust,et al.  An actin-based protrusion originating from a podosome-enriched region initiates macrophage fusion , 2019, bioRxiv.

[32]  R. Hass,et al.  In Vivo Cell Fusion between Mesenchymal Stroma/Stem-Like Cells and Breast Cancer Cells , 2019, Cancers.

[33]  M. Akhtar,et al.  Paget’s “Seed and Soil” Theory of Cancer Metastasis: An Idea Whose Time has Come , 2019, Advances in anatomic pathology.

[34]  Ying-Hui Huang,et al.  Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells , 2018, Journal of cellular physiology.

[35]  L. Chernomordik,et al.  Interactions with Muscle Cells Boost Fusion, Stemness, and Drug Resistance of Prostate Cancer Cells , 2018, Molecular Cancer Research.

[36]  T. Fujiwara,et al.  The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer , 2018, Journal of Experimental & Clinical Cancer Research.

[37]  Shinji Iizuka,et al.  Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival , 2018, Science Advances.

[38]  F. Noubissi,et al.  Breast tumor cell hybrids form spontaneously in vivo and contribute to breast tumor metastases , 2018, APL bioengineering.

[39]  R. Hass,et al.  In Vitro Fusion of Normal and Neoplastic Breast Epithelial Cells with Human Mesenchymal Stroma/Stem Cells Partially Involves Tumor Necrosis Factor Receptor Signaling , 2018, Stem cells.

[40]  J. Weiler,et al.  Matrix metalloproteinase-9 (MMP9) is involved in the TNF-α-induced fusion of human M13SV1-Cre breast epithelial cells and human MDA-MB-435-pFDR1 cancer cells , 2018, Cell Communication and Signaling.

[41]  Michael D. Brooks,et al.  Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. , 2018, Cell metabolism.

[42]  H. Ulrich,et al.  Kinin-B1 Receptor Stimulation Promotes Invasion and is Involved in Cell-Cell Interaction of Co-Cultured Glioblastoma and Mesenchymal Stem Cells , 2018, Scientific Reports.

[43]  R. Hass,et al.  Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC) , 2018, Cell Communication and Signaling.

[44]  Stephen C. Searles,et al.  Cell-cell fusion as a mechanism of DNA exchange in cancer , 2017, Oncotarget.

[45]  S. S. Kanwar,et al.  Phosphatidylserine: A cancer cell targeting biomarker. , 2017, Seminars in cancer biology.

[46]  L. D. White,et al.  EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells , 2017, Nature Communications.

[47]  N. Novère,et al.  Significance of stroma in biology of oral squamous cell carcinoma , 2018, Tumori.

[48]  Mohit Kumar Jolly,et al.  Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric. , 2017, Cancer research.

[49]  I. Shabo,et al.  Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity , 2017, Oncotarget.

[50]  A. Sacchetti,et al.  Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression , 2017, Neuro-oncology.

[51]  R. Weinberg,et al.  Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. , 2017, Cancer research.

[52]  J. Pawelek,et al.  A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis , 2017, PloS one.

[53]  Wang Min,et al.  Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. , 2016, The Journal of clinical investigation.

[54]  R. Birge,et al.  Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer , 2016, Cell Death and Differentiation.

[55]  T. Dittmar,et al.  Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial × Breast Cancer Hybrids, but Not in Parental Cells , 2016, PloS one.

[56]  P. Wegman,et al.  Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction , 2015, BMC Cancer.

[57]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[58]  Li Liu,et al.  Chemotherapy promotes tumour cell hybridization in vivo , 2015, Tumor Biology.

[59]  Wei Zhu,et al.  Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness , 2015, BMC Cancer.

[60]  X. Qi,et al.  Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium , 2015, Oncotarget.

[61]  K. Uzawa,et al.  Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis , 2015, PloS one.

[62]  T. Abraham,et al.  Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients , 2015, PloS one.

[63]  Brenda M Ogle,et al.  Apoptosis‐induced cancer cell fusion: a mechanism of breast cancer metastasis , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  S. Dutt,et al.  Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. , 2015, Carcinogenesis.

[65]  T. Dittmar,et al.  Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a Cre-LoxP-based double fluorescence reporter system , 2015, Cellular and Molecular Life Sciences.

[66]  Shuo Li,et al.  Mechanical tension drives cell membrane fusion. , 2015, Developmental cell.

[67]  Xianghui He,et al.  Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation , 2015, BMC Cancer.

[68]  K. Pfannkuche.  Cell Fusion , 2015, Methods in Molecular Biology.

[69]  Chunyan He,et al.  Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis , 2014, PloS one.

[70]  Cheng-Wen Wu,et al.  FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells , 2014, Oncotarget.

[71]  Zhenqing Feng,et al.  Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: an in vivo metastasis model. , 2014, Oncology reports.

[72]  V. Apostolopoulos,et al.  Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccines. , 2014, Anticancer research.

[73]  H. Arakawa,et al.  Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. , 2014, International journal of oncology.

[74]  W. Woodward,et al.  ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1 , 2014, Nature Cell Biology.

[75]  J. Lemmen,et al.  Syncytin-1 and its receptor is present in human gametes , 2014, Journal of Assisted Reproduction and Genetics.

[76]  Dan Luo,et al.  EMT and Acquisition of Stem Cell-Like Properties Are Involved in Spontaneous Formation of Tumorigenic Hybrids between Lung Cancer and Bone Marrow-Derived Mesenchymal Stem Cells , 2014, PloS one.

[77]  Yucai Wang,et al.  Purified Dendritic Cell-Tumor Fusion Hybrids Supplemented with Non-Adherent Dendritic Cells Fraction Are Superior Activators of Antitumor Immunity , 2014, PloS one.

[78]  H. Gal,et al.  Cell fusion induced by ERVWE1 or measles virus causes cellular senescence , 2013, Genes & development.

[79]  S. Capaccioli,et al.  Cell fusion promotes chemoresistance in metastatic colon carcinoma , 2013, Oncogene.

[80]  L. Chung,et al.  Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression , 2012, PloS one.

[81]  W. Jin,et al.  Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer , 2012, PloS one.

[82]  Z. Ju,et al.  Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells. , 2011, International journal of oncology.

[83]  Georg Krupitza,et al.  Initial steps of metastasis: Cell invasion and endothelial transmigration , 2011, Mutation research.

[84]  M. Wong,et al.  Inflammation and Proliferation Act Together to Mediate Intestinal Cell Fusion , 2009, PloS one.

[85]  Xin Lu,et al.  Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants , 2009, Proceedings of the National Academy of Sciences.

[86]  P. Bornstein,et al.  Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9 , 2009, Journal of leukocyte biology.

[87]  M. Grompe,et al.  Ploidy Reductions in Murine Fusion-Derived Hepatocytes , 2009, PLoS genetics.

[88]  G. Hu,et al.  Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. , 2008, Cancer research.

[89]  A. Chakraborty,et al.  The cancer cell--leukocyte fusion theory of metastasis. , 2008, Advances in cancer research.

[90]  G. Kroemer,et al.  Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. , 2007, Blood.

[91]  I. Christensen,et al.  Syncytin is involved in breast cancer-endothelial cell fusions , 2006, Cellular and Molecular Life Sciences CMLS.

[92]  J. Pawelek.  Tumour-cell fusion as a source of myeloid traits in cancer. , 2005, The Lancet. Oncology.

[93]  M. Qumsiyeh,et al.  Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT–tumor hybrids by FISH , 2005, Bone Marrow Transplantation.

[94]  F. Pontén,et al.  Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient , 2004, Bone Marrow Transplantation.

[95]  S. Segal,et al.  Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells , 2004, Cancer and Metastasis Reviews.

[96]  C. Reutelingsperger,et al.  Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. , 2001, Journal of cell science.

[97]  J. Pawelek.  Tumour cell hybridization and metastasis revisited , 2000, Melanoma research.

[98]  J. Mccoy,et al.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis , 2000, Nature.

[99]  I. Fidler,et al.  Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. , 1991, Cancer research.

[100]  D. McEachern,et al.  Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. , 1989, Cancer research.

[101]  S. R. Clark,et al.  Cell fusion segregates progressive growth from metastasis. , 1983, British Journal of Cancer.

[102]  T. Warner.  Cell hybridizaiton: an explanation for the phenotypic diversity of certain tumours. , 1975, Medical hypotheses.